Fred C. Tenover

52.4k citations

345 papers · 39.4k indexed · 11 hit papers · h-index 88

Impact in

Molecular Medicine top 0.01%
- Antibiotic Resistance in Bacteria
Clinical Biochemistry top 0.01%
- Bacterial Identification and Susceptibility Testing

Papers in

Clinical Biochemistry 163
- Bacterial Identification and Susceptibility Testing 163
Molecular Medicine 115
- Antibiotic Resistance in Bacteria 115

Co-authors: Richard V. Goering David H. Persing Barbara E. Murray R D Arbeit Bala Swaminathan P A Mickelsen Linda K. McDougal Christine D. Steward
Journals: Journal of Clinical Microbiology (94 papers)Antimicrobial Agents and Chemotherapy (44 papers)Clinical Infectious Diseases (23 papers)The Journal of Infectious Diseases (17 papers)Diagnostic Microbiology and Infectious Disease (15 papers)
Partner nations: United States Spain United Kingdom

In The Last Decade

Fred C. Tenover

343 papers receiving 37.4k citations

Hit Papers

11 papers align trajectories log scale

Better Tests, Better Care: Improved Diagnostics for Infectious Diseases 2013 · 461 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Clinical Infectious Diseases
2006 The American Journal of Medicine
2005 The Journal of Infectious Diseases
2005 New England Journal of Medicine
2003 Journal of Clinical Microbiology
2003 New England Journal of Medicine
2003 Science
2002 Journal of Clinical Microbiology
2001 Antimicrobial Agents and Chemotherapy
1999 New England Journal of Medicine
1995 Journal of Clinical Microbiology

Peers

Countries citing papers authored by Fred C. Tenover

Since Specialization

Citations

This map shows the geographic impact of Fred C. Tenover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred C. Tenover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred C. Tenover more than expected).

Fields of papers citing papers by Fred C. Tenover

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred C. Tenover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred C. Tenover. The network helps show where Fred C. Tenover may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fred C. Tenover, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fred C. Tenover Line = papers co-authored together Fred C. Tenover links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	History and Evolution of the Hypervirulent Clostridioides difficile Ribotype 027 Lineage Microorganisms ·Isabella A. Tickler, Richard V. Goering, Fred C. Tenover	2025	0
2	Genomic Analysis of Enterobacter Species Isolated from Patients in United States Hospitals Antibiotics ·Fred C. Tenover, Isabella A. Tickler	2024	2
3	Characterization of Beta-Lactamase and Fluoroquinolone Resistance Determinants in Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa Isolates from a Tertiary Hospital in Yola, Nigeria Tropical Medicine and Infectious Disease ·Shannon Bell Price, Isabella A. Tickler, Fred C. Tenover, 文雄班目	2023	4
4	Characterization of Carbapenemase- and ESBL-Producing Gram-Negative Bacilli Isolated from Patients with Urinary Tract and Bloodstream Infections Antibiotics ·Isabella A. Tickler, Shannon Bell Price, Luiz Chartuni Teixeira, Ferric C. Fang, Fred C. Tenover, (unknown)	2023	6
5	Phenotypic and genotypic discrepancies for carbapenemase-producing Citrobacter freundii in multiple isolates from a single patient Annals of Clinical Microbiology and Antimicrobials ·Stephen M. Brecher, Isabella A. Tickler, Fred C. Tenover	2023	2
6	Phylogenetic predictions of carbapenemase activity from the Guiana extended-spectrum (GES) family of β-lactamases JAC-Antimicrobial Resistance ·Miriam Barlow, Fred C. Tenover	2023	1
7	Carbapenemase-producing Pseudomonas aeruginosa –an emerging challenge Emerging Microbes & Infections ·Fred C. Tenover, David P. Nicolau, Christian M Gill	2022	124
8	Mechanisms of carbapenemase-mediated resistance among high-risk Pseudomonas aeruginosa lineages in Peru Journal of Global Antimicrobial Resistance ·Isabella A. Tickler, Juan Carlos Gómez de la Torre, Luis Alvarado, Luiz Chartuni Teixeira, Fred C. Tenover	2022	9
9	Detection of Methicillin-Resistant Staphylococcus aureus Infections Using Molecular Methods Antibiotics ·Fred C. Tenover, Isabella A. Tickler	2022	9
10	Does the presence of multiple β-lactamases in Gram-negative bacilli impact the results of antimicrobial susceptibility tests and extended-spectrum β-lactamase and carbapenemase confirmation methods? Journal of Global Antimicrobial Resistance ·Fred C. Tenover, Karla Esperanza, Scott Dewell, A.C. Evans, Isabella A. Tickler	2020	5
11	Continued expansion of USA300-like methicillin-resistant Staphylococcus aureus (MRSA) among hospitalized patients in the United States Diagnostic Microbiology and Infectious Disease ·Isabella A. Tickler, Richard V. Goering, José R. Mediavilla, Barry N. Kreiswirth, Fred C. Tenover	2017	30
12	Detection of Colonization by Carbapenemase-Producing Gram-Negative Bacilli in Patients by Use of the Xpert MDRO Assay Journal of Clinical Microbiology ·Fred C. Tenover, Rafael Cantón, 拓大前, Yuki Munemasa, Rachel Cruz, Fred Weir, Patricia Ruíz-Garbajosa, Vincent J. LaBombardi, David H. Persing	2013	67
13	Molecular microbiology: diagnostic principles and practice. Data Archiving and Networked Services (DANS) ·David H. Persing, Fred C. Tenover	2011	66
14	Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system Journal of Antimicrobial Chemotherapy ·Andrea Endimiani, Pranav Kalaga, V. H., Federico Pérez, Andrea M. Hujer, Burhan Habib, P.D. Fiorella, Prem A. Vyas, Brandon Kitchel, Clara Lucy Ferroco, Fred C. Tenover, Robert A. Bonomo	2009	118
15	Presence of Plasmid-Mediated Quinolone Resistance in Klebsiella pneumoniae Isolates Possessing bla _KPC in the United States Antimicrobial Agents and Chemotherapy ·Andrea Endimiani, Lenore L. Carias, Andrea M. Hujer, Christopher R. Bethel, Kristine M. Hujer, Federico Pérez, Rebecca A. Hutton, W. Fox, Geraldine S. Hall, Michael R. Jacobs, David L. Paterson, Louis B. Rice, Stephen G. Jenkins, Fred C. Tenover, Robert A. Bonomo	2008	83
16	Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversification Proceedings of the National Academy of Sciences ·Adam D. Kennedy, Michaël Otto, Kevin R. Braughton, Adeline R. Whitney, Liang Chen, Barun Mathema, José R. Mediavilla, Di-Yun Ruan, F Acs, Fred C. Tenover, Barry N. Kreiswirth, James M. Musser, Frank R. DeLeo	2008	300
17	Community-associated Methicillin-resistantStaphylococcus aureusand Healthcare Risk Factors Emerging infectious diseases ·R. Monina Klevens, Melissa Morrison, Scott K. Fridkin, Arthur Reingold, Susan Petit, Ken Gershman, Susan M. Ray, Lee H. Harrison, Ruth Lynfield, Ghinwa Dumyati, John M. Townes, Allen S. Craig, Gregory E. Fosheim, Linda K. McDougal, Fred C. Tenover	2006	167
18	Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus Science ·Linda M. Weigel, Don B. Clewell, Steven R. Gill, Nancye C. Clark, Linda K. McDougal, Susan E. Flannagan, James F. Kolonay, Jyoti Shetty, George Killgore, Fred C. Tenover Hit paper breakdown →	2003	668
19	Genetic Analyses of Mutations Contributing to Fluoroquinolone Resistance in Clinical Isolates of Streptococcus pneumoniae Antimicrobial Agents and Chemotherapy ·Linda M. Weigel, Gregory J. Anderson, Richard R. Facklam, Fred C. Tenover	2001	61
20	Increasing Resistance to Vancomycin and Other Glycopeptides in Staphylococcus aureus SHILAP Revista de lepidopterología ·Fred C. Tenover, James W. Biddle, Michael V. Lancaster	2001	25

About Fred C. Tenover

Fred C. Tenover is a scholar working on Clinical Biochemistry, Molecular Medicine, Applied Microbiology and Biotechnology, Infectious Diseases and Endocrinology, having authored 345 papers that have together received 39.4k indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (163 papers), Antimicrobial Resistance in Staphylococcus (153 papers), Antibiotic Resistance in Bacteria (115 papers), Bacterial biofilms and quorum sensing (56 papers), Antibiotics Pharmacokinetics and Efficacy (39 papers), Streptococcal Infections and Treatments (37 papers), Pneumonia and Respiratory Infections (37 papers) and Antibiotic Use and Resistance (35 papers). The work is most often cited by research in Molecular Medicine (10.9k citations), Clinical Biochemistry (12.3k citations), Applied Microbiology and Biotechnology (3.0k citations), Infectious Diseases (20.9k citations) and Endocrinology (4.8k citations). Fred C. Tenover has collaborated with scholars based in United States, Spain and United Kingdom. Frequent co-authors include Richard V. Goering, David H. Persing, Barbara E. Murray, R D Arbeit, Bala Swaminathan, P A Mickelsen, Linda K. McDougal, Christine D. Steward, George Killgore and Jana M. Swenson. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, The Journal of Infectious Diseases and Diagnostic Microbiology and Infectious Disease.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact